Leukemia, Myeloid, Acute
Showing NaN - NaN of 21
Leukemia, Myeloid, Acute Trial in Worldwide (Oral Azacitidine, Placebo)
Active, not recruiting
- Leukemia, Myeloid, Acute
- Oral Azacitidine
- Placebo
-
Phoenix, Arizona
- +247 more
Jan 13, 2023
Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,
Active, not recruiting
- Myelodysplastic Syndrome
- +2 more
-
Daphne, Alabama
- +241 more
Dec 23, 2022
MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)
Completed
- Myelodysplastic Syndromes
- +2 more
-
Birmingham, Alabama
- +58 more
Aug 24, 2022
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)
Recruiting
- Leukemia
- +19 more
- CYNK-001
-
Denver, Colorado
- +9 more
Sep 9, 2022
Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)
Active, not recruiting
- Leukemia, Myeloid, Acute
- AG-120
- +2 more
-
Duarte, California
- +72 more
Aug 18, 2022
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-90009)
Recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
New Haven, Connecticut
- +23 more
Aug 1, 2022
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)
Active, not recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Azacitidine
- Durvalumab
-
New Haven, Connecticut
- +94 more
Jun 9, 2022
Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- H3B-8800 (RVT-2001)
-
Stanford, California
- +26 more
Mar 23, 2022
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)
Recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
Marina Del Rey, California
- +35 more
Mar 11, 2022
Connect® Myeloid Disease Registry
Recruiting
- Primary Myelofibrosis
- +2 more
-
Huntsville, Alabama
- +228 more
Mar 30, 2021
Leukemia, Myeloid, Acute Trial in Australia, Korea, Republic of, United States (NLA101, Standard of Care (SOC) chemo)
Terminated
- Leukemia, Myeloid, Acute
- NLA101
- Standard of Care (SOC) chemotherapy
-
La Jolla, California
- +35 more
Mar 25, 2021
Leukemia, Myeloid, Acute Trial in Worldwide (SGI-110 (guadecitabine), Treatment Choice)
Completed
- Leukemia, Myeloid, Acute
- SGI-110 (guadecitabine)
- Treatment Choice
-
Scottsdale, Arizona
- +134 more
Dec 21, 2020
Leukemia, Myeloid, Acute, MDS Trial in United States (CC-90002)
Terminated
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
Phoenix, Arizona
- +5 more
Oct 17, 2018
Leukemia, Myeloid, Acute Trial in United States (BI 836858)
Completed
- Leukemia, Myeloid, Acute
- BI 836858
-
Chicago, Illinois
- +4 more
May 22, 2018
Leukemia, Myeloid, Acute, Hematologic Tumors Trial in France, United States (Pimasertib)
Terminated
- Leukemia, Myeloid, Acute
- Hematologic Neoplasms
-
Chicago, Illinois
- +8 more
Jul 19, 2017
Leukemia, Myeloid, Acute Trial in Australia, United States (CSL362)
Completed
- Leukemia, Myeloid, Acute
- CSL362
-
Chicago, Illinois
- +4 more
Oct 8, 2015
Leukemia, Myeloid, Acute Trial in United States (Troxatylâ„¢ (troxacitabine))
Terminated
- Leukemia, Myeloid, Acute
- Troxatylâ„¢ (troxacitabine)
-
LaJolla, California
- +19 more
Nov 1, 2006